These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32238802)

  • 1. Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.
    Zhu J; Kamara S; Cen D; Tang W; Gu M; Ci X; Chen J; Wang L; Zhu S; Jiang P; Chen S; Xue X; Zhang L
    Cell Death Dis; 2020 Apr; 11(4):213. PubMed ID: 32238802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma.
    Kamara S; Guo Y; Mao S; Ye X; Li Q; Zheng M; Zhu J; Zhang J; Du W; Chen J; Zhu S; Zhang L
    Appl Microbiol Biotechnol; 2021 Oct; 105(19):7283-7293. PubMed ID: 34505914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma.
    Kamara S; Guo Y; Wen H; Liu Y; Liu L; Zheng M; Zhang J; Zhou L; Chen J; Zhu S; Zhang L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Peroxiredoxin 1 Induced by Epstein-Barr Virus Infection in Nasopharyngeal Carcinoma.
    Noh MH; Kim HY; Kim DH; Moon SH; Hur DY
    Anticancer Res; 2024 Apr; 44(4):1425-1440. PubMed ID: 38537989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
    Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
    J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
    Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
    Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models.
    Guo Y; Kamara S; Zhang J; Wen H; Zheng M; Liu Y; Zhou L; Chen J; Zhu S; Zhang L
    Front Cell Infect Microbiol; 2022; 12():1078504. PubMed ID: 36683690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth.
    Huo H; Hu G
    Infect Agent Cancer; 2019; 14():30. PubMed ID: 31673282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
    Xie L; Shi F; Li Y; Li W; Yu X; Zhao L; Zhou M; Hu J; Luo X; Tang M; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Signal Transduct Target Ther; 2020 May; 5(1):56. PubMed ID: 32433544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
    Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human Fab exclusively binding to the extracellular domain of LMP2A.
    Cao Q; Zhang D; Mao Y; Meng C; Zhu J; Feng Z; Chen R
    Biochem Biophys Res Commun; 2017 Jan; 482(2):226-231. PubMed ID: 27845040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity.
    Zhu N; Xu X; Wang Y; Zeng MS; Yuan Y
    PLoS Pathog; 2021 Aug; 17(8):e1009873. PubMed ID: 34407150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
    Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis.
    Ikeda M; Hayes CK; Schaller SJ; Longnecker R
    Blood Adv; 2022 Jul; 6(14):4283-4296. PubMed ID: 35605249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
    Hau PM; Tsang CM; Yip YL; Huen MS; Tsao SW
    PLoS One; 2011; 6(6):e21176. PubMed ID: 21701587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.